More Dog Food Recalled Due To Aflatoxin



Published:

A Louisiana store, Petrus Feed & Seed, voluntarily recalled several lots of dry dog food because they contained aflatoxin above acceptable levels.

The food was manufactured at a Cargill plant in LeCompte, La., between Dec. 1, 2010, and Dec. 1, 2011.

The recall applies to 21 percent Protein Dog Food, packaged in 40-pound Petrus Feed bags with packaging date codes 4K1011 through 4K1335. The affected dry dog food was sold at Petrus Feed & Seed in Alexandria, La.

No adverse health effects related to the food have been reported, and Petrus said it implemented the recall as a precaution.

The company urged consumers to return any recalled food to the store for a full refund, regardless of whether the bags are opened or unopened.

Aflatoxin is a naturally occurring mold byproduct. Pets that consumed the recalled product and showed signs of sluggishness or lethargy combined with a reluctance to eat, vomiting, a yellowish tint to the eyes or gums, or diarrhea should be seen by a veterinarian, the company said.

Wet weather in the Midwest and central United States may have contributed to several companies recalling dry dog food in December because of heightened aflatoxin levels, including Cargill Animal NutritionProcter and Gamble and Advanced Animal Nutrition.

Wet conditions can stress corn, creating an ideal environment for aflatoxin to grow, according to Tina Wismer, DVM, medical director of the American Society for the Prevention of Cruelty to Animal’s Animal Poison Control Center.

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Two Suspects Arrested for Veterinarian's Death

Cynthia Campbell Eason, DVM, was murdered by her stepson and friend, according to police.

Midmark Animal Health Announces 'Bring It!' Promotion

Veterinary professionals who purchase certain equipment can receive a free anesthesia-monitoring course worth 4 hours of CE credit.

OVC Takes Part in Bone Cancer Clinical Trial

The University of Guelph’s Ontario Veterinary College is taking part in a clinical trial headed by the U.S. National Cancer Institute’s Comparative Oncology Trials Consortium, the first such collaboration between the two groups.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module